Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
ASX resources stocks with New Zealand projects
Coal Stocks Cobalt Stocks Copper Stocks Gold Stocks Graphite Stocks Iron Ore Stocks Lithium Stocks Mining Stocks Nickel Stocks Oil and Gas Stocks Palladium Stocks Rare Earths Stocks Silver stocks Uranium Stocks Vanadium Stocks
Here are 5 ASX resources stocks with New Zealand projects
In this article, we're taking a look at ASX resources stocks with New Zealand projects. It is easy for investors to disregard the country because of the basket case its economy has been, and the reputation of the country as being agriculturally-focused.Nonetheless, New Zealand does have an industry. It is no Western Australia, but the…
October 28, 20250Comments
Core Lithium
Lithium Stocks Mining Stocks Resources
Core Lithium (ASX:CXO): The share price has bottomed out, but will FY26 be the year it restarts Finniss
Core Lithium (ASX: CXO) was one of the hottest ASX stocks post-pandemic, not just lithium stocks but all stocks. The company began production at its Finniss Lithium Project in the Northern Territory during April 2023. However, Core Lithium timed its run pretty poorly. The past year was a volatile one for the company's…
October 27, 20250Comments
Telstra shares
Blue Chip Stocks Consumer Industrials Large Caps Market news Tech Stocks Technology Telecommunications Stocks
Telstra shares are at a 10-year high and the company is at an exciting point in its history
Last time we wrote about Telstra shares, it was in mid-FY24 and the company was under pressure. But 15 months on, things have improved with a strong FY25 and the company telling investors to expect the rest of the 2020s to deliver the goods. The company has never reached highs seen in 2015 since then,…
October 27, 20250Comments
Vertex Pharmaceuticals
Biotech Stocks Healthcare Stocks International Stocks Life Sciences
Vertex Pharmaceuticals (NDQ:VRTX): Another >US$100bn biotech that is facing the cliff like its peers, but might be safer
$100bn biotechs like Vertex Pharmaceuticals (NDQ:VRTX) typically get to their position through 'blockbuster drugs' with periods of market exclusivity, which eventually come to an end and cause revenues to fall as cheaper biosimilars come onto the market. The average biotech is facing a loss of revenue of 38%. Of course, some are higher (i.e. Amgen…
October 23, 20250Comments
South32
Blue Chip Stocks Coal Stocks Copper Stocks Large Caps Mining Stocks Nickel Stocks
South32 (ASX:S32): Is it the dark horse amongst ASX 200 miners or have cyclones and commodity prices hit it too hard?
South32 (ASX:S32) began life as a spinoff from BHP back in 2015, capitalised at $9bn. In mid-October 2025, it is capped at $14bn - not a bad effort considering spin-off companies can sometimes underperform. Just ask Falcon Minerals (ASX:FAL) and Minerals260 (ASX:260), which came out of Chalice and Liontown respectively.However, shares have been volatile, well…
October 22, 20250Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here